Edition:
United Kingdom

Astrazeneca Pharma India Ltd (ASTR.NS)

ASTR.NS on National Stock Exchange of India

1,977.00INR
5:48am GMT
Change (% chg)

Rs37.20 (+1.92%)
Prev Close
Rs1,939.80
Open
Rs1,935.00
Day's High
Rs1,980.00
Day's Low
Rs1,935.00
Volume
10,290
Avg. Vol
20,573
52-wk High
Rs2,135.00
52-wk Low
Rs919.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Dec 2,151.94 11.640
Sep 1,613.61 3.653
Jun 1,614.37 2.560
FY 2018 Mar '18 1,507.27 1.287
Dec 1,285.39 -4.141
Sep 1,642.58 10.954
Jun 1,284.66 2.320
FY 2017 Mar '17 1,168.86 -3.826
Dec 1,515.02 6.484
Sep 1,394.06 0.315
Jun 1,408.65 5.041
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 120.54 29.30 32.54
P/E High - Last 5 Yrs. 548.94 43.23 48.15
P/E Low - Last 5 Yrs. 95.66 22.71 23.42
Beta 0.50 0.86 0.87
Price to Sales (TTM) 4.49 6.59 8.39
Price to Book (MRQ) -- 5.12 5.27
Price to Tangible Book (MRQ) -- 5.84 6.74
Price to Cash Flow (TTM) 67.54 23.07 24.12
% Owned Institutions -- 0.87 1.65

Dividends

  Company industry sector
Dividend Yield -- 1.43 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.37
Dividend 5 Year Growth Rate -- 3.99 4.70
Payout Ratio(TTM) 0.00 42.18 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -8.80 5.43 13.45
Sales (TTM) vs TTM 1 Yr. Ago -7.71 6.61 8.02
Sales - 5 Yr. Growth Rate 0.30 10.48 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago -53.97 45.67 47.68
EPS (TTM) vs TTM 1 Yr. Ago 30.10 -- --
EPS - 5 Yr. Growth Rate 4.34 9.91 10.47
Capital Spending - 5 Yr. Growth Rate -32.37 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.07 2.18
Current Ratio (MRQ) -- 2.87 2.98
LT Debt to Equity (MRQ) -- 8.87 11.35
Total Debt to Equity (MRQ) -- 12.87 16.02
Interest Coverage (TTM) -- 32.47 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 66.88 52.10 52.41
Gross Margin - 5 Yr. Avg. 58.94 49.66 50.39
EBITD Margin (TTM) 3.71 -- --
EBITD - 5 Yr. Avg -1.89 17.26 12.43
Operating Margin (TTM) 0.79 13.53 5.77
Operating Margin - 5 Yr. Avg. -3.91 13.69 8.02
Pre-Tax Margin (TTM) 5.09 11.90 4.80
Pre-Tax Margin - 5 Yr. Avg. -2.10 14.10 8.31
Net Profit Margin (TTM) 3.72 8.81 1.53
Net Profit Margin - 5 Yr. Avg. -3.27 10.59 4.72
Effective Tax Rate (TTM) 26.88 22.12 22.13
Effective Tax Rate - 5 Yr. Avg. -- 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 4,631,859 928,328,910 820,340,906
Net Income/Employee (TTM) 172,405 105,131,990 92,858,384
Receivable Turnover (TTM) -- 5.84 5.82
Inventory Turnover (TTM) -- 2.57 3.41
Asset Turnover (TTM) -- 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.98 10.60
Return on Assets - 5 Yr. Avg. -4.28 12.41 11.78
Return on Investment (TTM) -- 14.23 13.82
Return on Investment - 5 Yr. Avg. -10.35 16.18 15.32
Return on Equity (TTM) -- 15.46 15.25
Return on Equity - 5 Yr. Avg. -10.64 17.07 16.41
  1 Year 3 Year 5 Year
Sales % -4.29 4.42 0.30
EPS (TTM) % 364.77 -- 4.34
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Astrazeneca Pharma India Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.27 1.86 99 31
13 Week -4.17 -5.54 99 42
26 Week 0.58 -6.08 99 45
52 Week 0.44 -11.26 99 9
YTD 2.48 -14.23 99 37
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.64%
# of Holders: 4
Total Shares Held: 1,409,930
3 Mo. Net Change: -21,913
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 1
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.